Lynn Seely insider trades

Open-market stock purchases and sales by Lynn Seely, President and CEO at Lyell Immunopharma, Inc, from SEC Form 4 filings since Dec 15, 2010.

Recent trades

DateStockTradeValue
Aug 21, 2026LYEL Lyell Immunopharma, IncSold$149K
Aug 10, 2026LYEL Lyell Immunopharma, IncSold$5.6K
May 11, 2026LYEL Lyell Immunopharma, IncSold$7.3K
Feb 11, 2026LYEL Lyell Immunopharma, IncSold$174K
Feb 10, 2026LYEL Lyell Immunopharma, IncBought (not open market)—
Feb 10, 2026LYEL Lyell Immunopharma, IncSold$10.1K
Feb 9, 2026LYEL Lyell Immunopharma, IncBought (not open market)—
Nov 10, 2025LYEL Lyell Immunopharma, IncSold$6.6K
Oct 27, 2025LYEL Lyell Immunopharma, IncBought (not open market)—

Companies traded

  • LYEL Lyell Immunopharma, Inc: 1 buy, 9 sales, last Aug 21, 2026
  • BPMC Blueprint Medicines Corp: other filings, last Jul 17, 2025
  • MYOV Myovant Sciences Ltd: other filings, last Apr 3, 2020
  • MDVN Medivation, Inc: 41 sales, last Feb 17, 2015

Get free alerts when Lynn Seely files a new trade →